1. Home
  2. FULC vs NATH Comparison

FULC vs NATH Comparison

Compare FULC & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.64

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$101.69

Market Cap

418.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
NATH
Founded
2015
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
418.8M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
FULC
NATH
Price
$3.64
$101.69
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$16.38
N/A
AVG Volume (30 Days)
4.2M
12.5K
Earning Date
04-27-2026
06-09-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
N/A
EPS
N/A
4.85
Revenue
N/A
$104,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.92
Revenue Growth
N/A
7.81
52 Week Low
$2.83
$88.67
52 Week High
$15.74
$117.49

Technical Indicators

Market Signals
Indicator
FULC
NATH
Relative Strength Index (RSI) 32.75 51.38
Support Level $2.83 $100.26
Resistance Level $8.18 $101.76
Average True Range (ATR) 0.27 0.66
MACD 0.02 -0.03
Stochastic Oscillator 20.76 22.64

Price Performance

Historical Comparison
FULC
NATH

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: